| Â | Â | ACTUAL TREATMENT |
|---|
AASLD INDICATIONS | Â | RESECTION | OLTx | PEI/RFTA | TACE/ PEI+TACE | BSC |
|---|
| Â | RESECTION |
30 (28%)
| 1 (1%) | 44 (40%) | 27 (25%) | 7 (6%) |
| Â | OLTx | 6 (9%) |
6(9%) | 9 (14%) | 34 (52%) | 11(16%) |
| Â | PEI or RFTA | 32 (13%) | 4 (2%) |
83 (34%)
| 88 (36%) | 37(15%) |
- OLTx: orthotopic liver transplantation; RFTA: radiofrequency-mediated thermal ablation; PEI: percutaneous ethanol injection; TACE: transcatheter arterial chemoembolization; BSC: best supportive care.
- AASLD indications for treatment are reported in rows; percentages of patients treated per each modality are calculated on the totality of patients having that specific indication.
- The adherence to AASLD indication was evaluated when all data were available (419/465 pts – 90%).
